Sign In
Buy SENS
$5.03
-0.0400 (-0.789%)
At Close: Jul 31, 2026
Senseonics: Eversense 365 Is A Game Changer For The CGM Industry
10:18am, Friday, 19'th Dec 2025
Senseonics Holdings earns a buy rating as Eversense 365 drives potential product-market fit and margin expansion. SENS's integration of Ascensia's commercial team and DTC investments is expected to bo
Senseonics Holdings, Inc. (SENS) Q3 2025 Earnings Call Transcript
08:41pm, Wednesday, 05'th Nov 2025
Senseonics Holdings, Inc. ( SENS ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Tim Goodnow - President, CEO & Director Frederick Sullivan - CFO, Secretary & Treasurer Confe
Senseonics Holdings (SENS) Reports Q3 Loss, Beats Revenue Estimates
08:06pm, Wednesday, 05'th Nov 2025
Senseonics Holdings (SENS) came out with a quarterly loss of $0.43 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to a loss of $0.8 per share a year ago.
Senseonics Holdings (SENS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:07am, Wednesday, 29'th Oct 2025
Senseonics (SENS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time
04:05pm, Wednesday, 22'nd Oct 2025
GERMANTOWN, Md., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable
Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update
04:05pm, Monday, 06'th Oct 2025
Preliminary unaudited revenue of $8.1 million for Q3 2025 Generated record quarterly new patient starts in Q3 2025 Established reverse stock split ratio of 1:20, anticipated to be effective October 17
Senseonics Holdings, Inc. (SENS) Eversense 365 Commercial Update Call (Transcript)
11:23am, Thursday, 04'th Sep 2025
Senseonics Holdings, Inc. (NYSE:SENS ) Eversense 365 Commercial Update Conference Company Participants Tim Goodnow - President, CEO & Director Frederick Sullivan - CFO, Secretary & Treasurer Conferenc
Ascensia Diabetes Care Signs MOU to Transfer Eversense® CGM Distribution to Strategic Partner Senseonics
07:22pm, Wednesday, 03'rd Sep 2025
TOKYO--(BUSINESS WIRE)--PHC Holdings Corporation (President, Representative Director and CEO: Kyoko Deguchi, TSE: 6523) and its subsidiary Ascensia Diabetes Care, a global diabetes care company, today
Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365
05:17pm, Wednesday, 03'rd Sep 2025
CGM commercial operations to transition from Ascensia Diabetes Care to Senseonics Brian Hansen to be appointed Chief Commercial Officer Non-dilutive debt facility expanded up to $100 million with Herc
Here's Why Senseonics (SENS) Is a Great 'Buy the Bottom' Stock Now
10:56am, Thursday, 21'st Aug 2025
Senseonics (SENS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wal
Senseonics Holdings, Inc. (SENS) Q2 2025 Earnings Call Transcript
07:42pm, Wednesday, 06'th Aug 2025
Senseonics Holdings, Inc. (NYSE:SENS ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Frederick T. Sullivan - CFO, Secretary & Treasurer Mukul Jain - Chief Operating O
Senseonics Holdings (SENS) Reports Q2 Loss, Tops Revenue Estimates
07:11pm, Wednesday, 06'th Aug 2025
Senseonics Holdings (SENS) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
04:05pm, Wednesday, 06'th Aug 2025
Generated Q2 revenue of $6.6 million, representing year-over-year growth of 37% Achieved a 79% increase in U.S. new patient starts over prior year GERMANTOWN, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Se
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
04:05pm, Wednesday, 16'th Jul 2025
GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable
Here's Why Senseonics (SENS) is Poised for a Turnaround After Losing 5.7% in 4 Weeks
10:35am, Wednesday, 18'th Jun 2025
The heavy selling pressure might have exhausted for Senseonics (SENS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts
